Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Change in Receivables (2021 - 2025)

Historic Change in Receivables for Biofrontera (BFRIW) over the last 5 years, with Q3 2025 value amounting to -$947000.0.

  • Biofrontera's Change in Receivables fell 16745.01% to -$947000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year decrease of 26216.45%. This contributed to the annual value of $315000.0 for FY2024, which is 7949.22% down from last year.
  • As of Q3 2025, Biofrontera's Change in Receivables stood at -$947000.0, which was down 16745.01% from -$88000.0 recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Change in Receivables peaked at $2.2 million during Q4 2022, and registered a low of -$3.1 million during Q2 2022.
  • For the 5-year period, Biofrontera's Change in Receivables averaged around $8842.1, with its median value being $10000.0 (2021).
  • In the last 5 years, Biofrontera's Change in Receivables crashed by 3090000.0% in 2022 and then soared by 46767.9% in 2023.
  • Over the past 5 years, Biofrontera's Change in Receivables (Quarter) stood at $1.8 million in 2021, then rose by 19.7% to $2.2 million in 2022, then plummeted by 38.93% to $1.3 million in 2023, then plummeted by 63.06% to $492000.0 in 2024, then crashed by 292.48% to -$947000.0 in 2025.
  • Its Change in Receivables stands at -$947000.0 for Q3 2025, versus -$88000.0 for Q2 2025 and -$1.3 million for Q1 2025.